カテゴリー： 世界, 医療/バイオ, LP Information

世界の自己免疫疾患用薬物送達装置市場予測 2023年-2029年

【英語タイトル】Global Autoimmune Disorder Drug Delivery Devices Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4115）・商品コード：LP23MY4115
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：128
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の自己免疫疾患用薬物送達装置市場」は、過去の販売実績から2022年の世界の自己免疫疾患用薬物送達装置の総販売量を検討し、2023年から2029年の予測される自己免疫疾患用薬物送達装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の自己免疫疾患用薬物送達装置の市場規模を掲載し、XXX百万米ドル規模の世界の自己免疫疾患用薬物送達装置市場の詳細な分析を提供します。本インサイトレポートは、世界の自己免疫疾患用薬物送達装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の自己免疫疾患用薬物送達装置市場における各社の独自のポジションをより深く理解するために、自己免疫疾患用薬物送達装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の自己免疫疾患用薬物送達装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。自己免疫疾患用薬物送達装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。自己免疫疾患用薬物送達装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。自己免疫疾患用薬物送達装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

自己免疫疾患用薬物送達装置の世界主要メーカーとしては、BD、 Gerresheimer、 Schott、 J.O.Pharma、 Nipro、 Roselabs、 Fresenius Kabi、 Baxter、 West Pharma、 Terumo、 Taisei Kako、 MedXL、 Cardinal Health、 Guerbet、 Catalent、 Weigao、 Stevanato、 Rovi CM、 Zibo Minkang、 Vetter Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の自己免疫疾患用薬物送達装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では自己免疫疾患用薬物送達装置市場をセグメンテーションし、種類別 (ペンインジェクター、自動インジェクター、プレフィルドシリンジ、バイアル)、用途別 (病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ペンインジェクター、自動インジェクター、プレフィルドシリンジ、バイアル

・用途別区分：病院、診療所

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の自己免疫疾患用薬物送達装置市場の10年間の市場状況・展望は？
・世界および地域別に見た自己免疫疾患用薬物送達装置市場成長の要因は何か？
・自己免疫疾患用薬物送達装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・自己免疫疾患用薬物送達装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：自己免疫疾患用薬物送達装置の年間販売量2018-2029、地域別現状・将来分析
・自己免疫疾患用薬物送達装置の種類別セグメント：ペンインジェクター、自動インジェクター、プレフィルドシリンジ、バイアル
・自己免疫疾患用薬物送達装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・自己免疫疾患用薬物送達装置の用途別セグメント：病院、診療所
・自己免疫疾患用薬物送達装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の自己免疫疾患用薬物送達装置市場
・企業別のグローバル自己免疫疾患用薬物送達装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の自己免疫疾患用薬物送達装置の年間売上：2018-2023年の売上、市場シェア
・企業別の自己免疫疾患用薬物送達装置販売価格
・主要企業の自己免疫疾患用薬物送達装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

自己免疫疾患用薬物送達装置の地域別レビュー
・地域別の自己免疫疾患用薬物送達装置市場規模2018-2023：年間販売量、売上
・主要国別の自己免疫疾患用薬物送達装置市場規模2018-2023：年間販売量、売上
・南北アメリカの自己免疫疾患用薬物送達装置販売の成長
・アジア太平洋の自己免疫疾患用薬物送達装置販売の成長
・ヨーロッパの自己免疫疾患用薬物送達装置販売の成長
・中東・アフリカの自己免疫疾患用薬物送達装置販売の成長

南北アメリカ市場
・南北アメリカの国別の自己免疫疾患用薬物送達装置販売量、売上（2018-2023）
・南北アメリカの自己免疫疾患用薬物送達装置の種類別販売量
・南北アメリカの自己免疫疾患用薬物送達装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の自己免疫疾患用薬物送達装置販売量、売上（2018-2023）
・アジア太平洋の自己免疫疾患用薬物送達装置の種類別販売量
・アジア太平洋の自己免疫疾患用薬物送達装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の自己免疫疾患用薬物送達装置販売量、売上（2018-2023）
・ヨーロッパの自己免疫疾患用薬物送達装置の種類別販売量
・ヨーロッパの自己免疫疾患用薬物送達装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の自己免疫疾患用薬物送達装置販売量、売上（2018-2023）
・中東・アフリカの自己免疫疾患用薬物送達装置の種類別販売量
・中東・アフリカの自己免疫疾患用薬物送達装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・自己免疫疾患用薬物送達装置の製造コスト構造分析
・自己免疫疾患用薬物送達装置の製造プロセス分析
・自己免疫疾患用薬物送達装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・自己免疫疾患用薬物送達装置の主要なグローバル販売業者
・自己免疫疾患用薬物送達装置の主要なグローバル顧客

地域別の自己免疫疾患用薬物送達装置市場予測レビュー
・地域別の自己免疫疾患用薬物送達装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・自己免疫疾患用薬物送達装置の種類別市場規模予測
・自己免疫疾患用薬物送達装置の用途別市場規模予測

主要企業分析
BD、 Gerresheimer、 Schott、 J.O.Pharma、 Nipro、 Roselabs、 Fresenius Kabi、 Baxter、 West Pharma、 Terumo、 Taisei Kako、 MedXL、 Cardinal Health、 Guerbet、 Catalent、 Weigao、 Stevanato、 Rovi CM、 Zibo Minkang、 Vetter Pharma
・企業情報
・自己免疫疾患用薬物送達装置製品
・自己免疫疾患用薬物送達装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Autoimmune Disorder Drug Delivery Devices Industry Forecast” looks at past sales and reviews total world Autoimmune Disorder Drug Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Autoimmune Disorder Drug Delivery Devices sales for 2023 through 2029. With Autoimmune Disorder Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disorder Drug Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Autoimmune Disorder Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmune Disorder Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmune Disorder Drug Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disorder Drug Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disorder Drug Delivery Devices.
The global Autoimmune Disorder Drug Delivery Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Autoimmune Disorder Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Autoimmune Disorder Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Autoimmune Disorder Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Autoimmune Disorder Drug Delivery Devices players cover BD, Gerresheimer, Schott, J.O.Pharma, Nipro, Roselabs, Fresenius Kabi, Baxter and West Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disorder Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Pen Injectors
Auto-Injectors
Pre-filled Syringes
Vials
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BD
Gerresheimer
Schott
J.O.Pharma
Nipro
Roselabs
Fresenius Kabi
Baxter
West Pharma
Terumo
Taisei Kako
MedXL
Cardinal Health
Guerbet
Catalent
Weigao
Stevanato
Rovi CM
Zibo Minkang
Vetter Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Autoimmune Disorder Drug Delivery Devices market?
What factors are driving Autoimmune Disorder Drug Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autoimmune Disorder Drug Delivery Devices market opportunities vary by end market size?
How does Autoimmune Disorder Drug Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disorder Drug Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Autoimmune Disorder Drug Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Autoimmune Disorder Drug Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Autoimmune Disorder Drug Delivery Devices Segment by Type
2.2.1 Pen Injectors
2.2.2 Auto-Injectors
2.2.3 Pre-filled Syringes
2.2.4 Vials
2.3 Autoimmune Disorder Drug Delivery Devices Sales by Type
2.3.1 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Autoimmune Disorder Drug Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Autoimmune Disorder Drug Delivery Devices Sale Price by Type (2018-2023)
2.4 Autoimmune Disorder Drug Delivery Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Autoimmune Disorder Drug Delivery Devices Sales by Application
2.5.1 Global Autoimmune Disorder Drug Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Autoimmune Disorder Drug Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Autoimmune Disorder Drug Delivery Devices Sale Price by Application (2018-2023)
3 Global Autoimmune Disorder Drug Delivery Devices by Company
3.1 Global Autoimmune Disorder Drug Delivery Devices Breakdown Data by Company
3.1.1 Global Autoimmune Disorder Drug Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Autoimmune Disorder Drug Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Autoimmune Disorder Drug Delivery Devices Sale Price by Company
3.4 Key Manufacturers Autoimmune Disorder Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autoimmune Disorder Drug Delivery Devices Product Location Distribution
3.4.2 Players Autoimmune Disorder Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Autoimmune Disorder Drug Delivery Devices by Geographic Region
4.1 World Historic Autoimmune Disorder Drug Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Autoimmune Disorder Drug Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Autoimmune Disorder Drug Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Autoimmune Disorder Drug Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Autoimmune Disorder Drug Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Autoimmune Disorder Drug Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Autoimmune Disorder Drug Delivery Devices Sales Growth
4.4 APAC Autoimmune Disorder Drug Delivery Devices Sales Growth
4.5 Europe Autoimmune Disorder Drug Delivery Devices Sales Growth
4.6 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Growth
5 Americas
5.1 Americas Autoimmune Disorder Drug Delivery Devices Sales by Country
5.1.1 Americas Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Autoimmune Disorder Drug Delivery Devices Sales by Type
5.3 Americas Autoimmune Disorder Drug Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disorder Drug Delivery Devices Sales by Region
6.1.1 APAC Autoimmune Disorder Drug Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Autoimmune Disorder Drug Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Autoimmune Disorder Drug Delivery Devices Sales by Type
6.3 APAC Autoimmune Disorder Drug Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Autoimmune Disorder Drug Delivery Devices by Country
7.1.1 Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Autoimmune Disorder Drug Delivery Devices Sales by Type
7.3 Europe Autoimmune Disorder Drug Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disorder Drug Delivery Devices by Country
8.1.1 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Type
8.3 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autoimmune Disorder Drug Delivery Devices
10.3 Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Devices
10.4 Industry Chain Structure of Autoimmune Disorder Drug Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autoimmune Disorder Drug Delivery Devices Distributors
11.3 Autoimmune Disorder Drug Delivery Devices Customer
12 World Forecast Review for Autoimmune Disorder Drug Delivery Devices by Geographic Region
12.1 Global Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Region
12.1.1 Global Autoimmune Disorder Drug Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Autoimmune Disorder Drug Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Autoimmune Disorder Drug Delivery Devices Forecast by Type
12.7 Global Autoimmune Disorder Drug Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.1.3 BD Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Gerresheimer
13.2.1 Gerresheimer Company Information
13.2.2 Gerresheimer Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.2.3 Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Gerresheimer Main Business Overview
13.2.5 Gerresheimer Latest Developments
13.3 Schott
13.3.1 Schott Company Information
13.3.2 Schott Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.3.3 Schott Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Schott Main Business Overview
13.3.5 Schott Latest Developments
13.4 J.O.Pharma
13.4.1 J.O.Pharma Company Information
13.4.2 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.4.3 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 J.O.Pharma Main Business Overview
13.4.5 J.O.Pharma Latest Developments
13.5 Nipro
13.5.1 Nipro Company Information
13.5.2 Nipro Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.5.3 Nipro Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nipro Main Business Overview
13.5.5 Nipro Latest Developments
13.6 Roselabs
13.6.1 Roselabs Company Information
13.6.2 Roselabs Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.6.3 Roselabs Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roselabs Main Business Overview
13.6.5 Roselabs Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.7.3 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Baxter
13.8.1 Baxter Company Information
13.8.2 Baxter Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.8.3 Baxter Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Baxter Main Business Overview
13.8.5 Baxter Latest Developments
13.9 West Pharma
13.9.1 West Pharma Company Information
13.9.2 West Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.9.3 West Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 West Pharma Main Business Overview
13.9.5 West Pharma Latest Developments
13.10 Terumo
13.10.1 Terumo Company Information
13.10.2 Terumo Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.10.3 Terumo Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Terumo Main Business Overview
13.10.5 Terumo Latest Developments
13.11 Taisei Kako
13.11.1 Taisei Kako Company Information
13.11.2 Taisei Kako Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.11.3 Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Taisei Kako Main Business Overview
13.11.5 Taisei Kako Latest Developments
13.12 MedXL
13.12.1 MedXL Company Information
13.12.2 MedXL Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.12.3 MedXL Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 MedXL Main Business Overview
13.12.5 MedXL Latest Developments
13.13 Cardinal Health
13.13.1 Cardinal Health Company Information
13.13.2 Cardinal Health Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.13.3 Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Cardinal Health Main Business Overview
13.13.5 Cardinal Health Latest Developments
13.14 Guerbet
13.14.1 Guerbet Company Information
13.14.2 Guerbet Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.14.3 Guerbet Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Guerbet Main Business Overview
13.14.5 Guerbet Latest Developments
13.15 Catalent
13.15.1 Catalent Company Information
13.15.2 Catalent Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.15.3 Catalent Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Catalent Main Business Overview
13.15.5 Catalent Latest Developments
13.16 Weigao
13.16.1 Weigao Company Information
13.16.2 Weigao Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.16.3 Weigao Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Weigao Main Business Overview
13.16.5 Weigao Latest Developments
13.17 Stevanato
13.17.1 Stevanato Company Information
13.17.2 Stevanato Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.17.3 Stevanato Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Stevanato Main Business Overview
13.17.5 Stevanato Latest Developments
13.18 Rovi CM
13.18.1 Rovi CM Company Information
13.18.2 Rovi CM Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.18.3 Rovi CM Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Rovi CM Main Business Overview
13.18.5 Rovi CM Latest Developments
13.19 Zibo Minkang
13.19.1 Zibo Minkang Company Information
13.19.2 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.19.3 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Zibo Minkang Main Business Overview
13.19.5 Zibo Minkang Latest Developments
13.20 Vetter Pharma
13.20.1 Vetter Pharma Company Information
13.20.2 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
13.20.3 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Vetter Pharma Main Business Overview
13.20.5 Vetter Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Autoimmune Disorder Drug Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Autoimmune Disorder Drug Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Pen Injectors
Table 4. Major Players of Auto-Injectors
Table 5. Major Players of Pre-filled Syringes
Table 6. Major Players of Vials
Table 7. Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 8. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
Table 9. Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2018-2023) & ($ million)
Table 10. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Table 11. Global Autoimmune Disorder Drug Delivery Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 13. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2023)
Table 14. Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2018-2023)
Table 15. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2018-2023)
Table 16. Global Autoimmune Disorder Drug Delivery Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Autoimmune Disorder Drug Delivery Devices Sales by Company (2018-2023) & (K Units)
Table 18. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Company (2018-2023)
Table 19. Global Autoimmune Disorder Drug Delivery Devices Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company (2018-2023)
Table 21. Global Autoimmune Disorder Drug Delivery Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Autoimmune Disorder Drug Delivery Devices Producing Area Distribution and Sales Area
Table 23. Players Autoimmune Disorder Drug Delivery Devices Products Offered
Table 24. Autoimmune Disorder Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Autoimmune Disorder Drug Delivery Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share Geographic Region (2018-2023)
Table 29. Global Autoimmune Disorder Drug Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Autoimmune Disorder Drug Delivery Devices Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country/Region (2018-2023)
Table 33. Global Autoimmune Disorder Drug Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 36. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 37. Americas Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 39. Americas Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 40. Americas Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 41. APAC Autoimmune Disorder Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 42. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2018-2023)
Table 43. APAC Autoimmune Disorder Drug Delivery Devices Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Table 45. APAC Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 46. APAC Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 47. Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 48. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 49. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 51. Europe Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 52. Europe Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Autoimmune Disorder Drug Delivery Devices
Table 60. Key Market Challenges & Risks of Autoimmune Disorder Drug Delivery Devices
Table 61. Key Industry Trends of Autoimmune Disorder Drug Delivery Devices
Table 62. Autoimmune Disorder Drug Delivery Devices Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Autoimmune Disorder Drug Delivery Devices Distributors List
Table 65. Autoimmune Disorder Drug Delivery Devices Customer List
Table 66. Global Autoimmune Disorder Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Autoimmune Disorder Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Autoimmune Disorder Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Autoimmune Disorder Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Autoimmune Disorder Drug Delivery Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Autoimmune Disorder Drug Delivery Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. BD Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 81. BD Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 82. BD Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. BD Main Business
Table 84. BD Latest Developments
Table 85. Gerresheimer Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 86. Gerresheimer Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 87. Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Gerresheimer Main Business
Table 89. Gerresheimer Latest Developments
Table 90. Schott Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 91. Schott Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 92. Schott Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Schott Main Business
Table 94. Schott Latest Developments
Table 95. J.O.Pharma Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 96. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 97. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. J.O.Pharma Main Business
Table 99. J.O.Pharma Latest Developments
Table 100. Nipro Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 101. Nipro Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 102. Nipro Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Nipro Main Business
Table 104. Nipro Latest Developments
Table 105. Roselabs Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. Roselabs Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 107. Roselabs Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Roselabs Main Business
Table 109. Roselabs Latest Developments
Table 110. Fresenius Kabi Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 111. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 112. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Fresenius Kabi Main Business
Table 114. Fresenius Kabi Latest Developments
Table 115. Baxter Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 116. Baxter Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 117. Baxter Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Baxter Main Business
Table 119. Baxter Latest Developments
Table 120. West Pharma Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 121. West Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 122. West Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. West Pharma Main Business
Table 124. West Pharma Latest Developments
Table 125. Terumo Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 126. Terumo Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 127. Terumo Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Terumo Main Business
Table 129. Terumo Latest Developments
Table 130. Taisei Kako Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 131. Taisei Kako Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 132. Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Taisei Kako Main Business
Table 134. Taisei Kako Latest Developments
Table 135. MedXL Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 136. MedXL Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 137. MedXL Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. MedXL Main Business
Table 139. MedXL Latest Developments
Table 140. Cardinal Health Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 141. Cardinal Health Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 142. Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Cardinal Health Main Business
Table 144. Cardinal Health Latest Developments
Table 145. Guerbet Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 146. Guerbet Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 147. Guerbet Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Guerbet Main Business
Table 149. Guerbet Latest Developments
Table 150. Catalent Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 151. Catalent Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 152. Catalent Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Catalent Main Business
Table 154. Catalent Latest Developments
Table 155. Weigao Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 156. Weigao Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 157. Weigao Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Weigao Main Business
Table 159. Weigao Latest Developments
Table 160. Stevanato Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 161. Stevanato Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 162. Stevanato Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Stevanato Main Business
Table 164. Stevanato Latest Developments
Table 165. Rovi CM Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 166. Rovi CM Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 167. Rovi CM Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Rovi CM Main Business
Table 169. Rovi CM Latest Developments
Table 170. Zibo Minkang Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 171. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 172. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Zibo Minkang Main Business
Table 174. Zibo Minkang Latest Developments
Table 175. Vetter Pharma Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 176. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolios and Specifications
Table 177. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Vetter Pharma Main Business
Table 179. Vetter Pharma Latest Developments
List of Figures
Figure 1. Picture of Autoimmune Disorder Drug Delivery Devices
Figure 2. Autoimmune Disorder Drug Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autoimmune Disorder Drug Delivery Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Autoimmune Disorder Drug Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Pen Injectors
Figure 10. Product Picture of Auto-Injectors
Figure 11. Product Picture of Pre-filled Syringes
Figure 12. Product Picture of Vials
Figure 13. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type in 2022
Figure 14. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Figure 15. Autoimmune Disorder Drug Delivery Devices Consumed in Hospital
Figure 16. Global Autoimmune Disorder Drug Delivery Devices Market: Hospital (2018-2023) & (K Units)
Figure 17. Autoimmune Disorder Drug Delivery Devices Consumed in Clinic
Figure 18. Global Autoimmune Disorder Drug Delivery Devices Market: Clinic (2018-2023) & (K Units)
Figure 19. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2022)
Figure 20. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application in 2022
Figure 21. Autoimmune Disorder Drug Delivery Devices Sales Market by Company in 2022 (K Units)
Figure 22. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Company in 2022
Figure 23. Autoimmune Disorder Drug Delivery Devices Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company in 2022
Figure 25. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Autoimmune Disorder Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 28. Americas Autoimmune Disorder Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 29. APAC Autoimmune Disorder Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 30. APAC Autoimmune Disorder Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 31. Europe Autoimmune Disorder Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 32. Europe Autoimmune Disorder Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 35. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country in 2022
Figure 36. Americas Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 37. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 38. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 39. United States Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region in 2022
Figure 44. APAC Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Regions in 2022
Figure 45. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 46. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 47. China Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country in 2022
Figure 55. Europe Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 56. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 57. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 58. Germany Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 67. Egypt Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Autoimmune Disorder Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Autoimmune Disorder Drug Delivery Devices in 2022
Figure 73. Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Devices
Figure 74. Industry Chain Structure of Autoimmune Disorder Drug Delivery Devices
Figure 75. Channels of Distribution
Figure 76. Global Autoimmune Disorder Drug Delivery Devices Sales Market Forecast by Region (2024-2029)
Figure 77. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報

自己免疫疾患は、免疫系が自己の細胞や組織を誤って攻撃することによって引き起こされる一連の病状を指します。このような疾患には、関節リウマチ、全身性エリテマトーデス、クローン病などが含まれます。これらの疾患は慢性的な症状を引き起こし、患者の生活の質を大きく損なう可能性があります。自己免疫疾患の治療には免疫抑制剤や抗炎症薬が主に使用されるため、これらの薬剤の投与が極めて重要です。ここで注目されるのが、自己免疫疾患用の薬物送達装置です。

薬物送達装置とは、特定の医薬品を必要な部位に効果的に届けるための技術や機器のことを言います。特に自己免疫疾患においては、患者の状態や服薬の遵守状況を考慮する必要があるため、薬物送達システムの選択は重要です。自己免疫疾患用の薬物送達装置は、これらのニーズに応えるためにさまざまな特徴を持っています。

まず、自己免疫疾患用薬物送達装置の特徴には、精密性、持続性、安全性、使いやすさが挙げられます。精密性は、薬剤が正確に必要な部位に到達することを意味します。自己免疫疾患の治療は、特定の臓器や組織における免疫反応の抑制が目的であり、このために精密な送達が必須です。持続性は、薬剤が長時間にわたって効果的に作用することを指し、一度の投与で長期間の治療効果を得られることが患者にとっての利点です。

安全性については、投与される薬剤が副作用を引き起こさないように設計されていることが求められます。特に自己免疫疾患の患者は、もともと免疫系に異常があるため、余計な免疫応答を誘発しないよう配慮が必要です。また、使いやすさも重要な要素であり、患者自身が容易に使用できる設計が求められます。

次に、自己免疫疾患用薬物送達装置の種類について言及します。代表的なものには、注射器型、自動投与ポンプ、経皮吸収システム、ナノ粒子送達システムなどがあります。注射器型は、最も一般的な送達方法であり、医療機関や自宅で注射を行うことができるため、患者にとって手軽です。一方、自動投与ポンプは、設定された時間に自動で薬剤を投与する装置であり、患者の負担を軽減することができます。

経皮吸収システムは、皮膚を通じて薬剤を体内にうまく届ける技術です。この方式は、経口摂取が難しい患者や、注射を好まない患者に対して有用です。ナノ粒子送達システムは、ナノサイズのキャリアを使用して薬剤を特定の細胞や組織に直接届ける方法であり、効果的かつ副作用の少ない治療を実現する可能性があります。

薬物送達装置の用途は多岐にわたります。自己免疫疾患に特化した治療だけでなく、他の疾病に対する治療法の開発にも寄与しています。たとえば、炎症を抑えるための薬剤や、免疫系を調整するための生物学的製剤などがあり、これらは自己免疫疾患患者の治療に直結します。さらに、研究の進展により、より新しい薬物送達システムが開発され、治療の選択肢が広がっています。

関連技術としては、バイオマテリアルやドラッグデリバリーシステム、ナノテクノロジーが挙げられます。バイオマテリアルは、生体適合性があり、人体内での使用が安全な材料として注目されており、薬物送達装置の一部に利用されています。特に、自己免疫疾患においては、炎症反応を抑えるための設計が求められます。ドラッグデリバリーシステムとナノテクノロジーに基づいた新しい方法は、薬剤の効果を最大限引き出し、副作用を最小限に抑えることを目指しています。

自己免疫疾患用薬物送達装置の今後の展望についても触れておきます。従来の方法に加え、新しい技術や材料の開発が進むことで、より効果的な治療が期待されています。特に、個別化医療の観点からも、患者一人ひとりの体質や状態に合ったパーソナライズドな薬物送達システムの実現が望まれています。

自己免疫疾患の治療における薬物送達装置は、患者の生活の質を大きく向上させる可能性を秘めています。今後の研究や技術の進展により、より効果的かつ安全な治療法が提供されることを期待しています。これにより、多くの患者が自らの疾患と向き合いながら、より良い生活を送ることができるようになることが求められています。


★調査レポート[世界の自己免疫疾患用薬物送達装置市場予測 2023年-2029年] (コード：LP23MY4115)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の自己免疫疾患用薬物送達装置市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆